How is PMCB intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for PMCB.
Intrinsic value of PharmaCyte Biotech, Inc. (PMCB)
Live valuation data for PharmaCyte Biotech, Inc. (PMCB) is not available right now. Please try again shortly.
Intrinsic Value (Fair Value): Unlock fair value
Downside: Data not available
Margin of Safety: Unlock fair value
Current Price: $360.00
Valuation: Data not available
Confidence: Data not available
Visual Bar
Market Price $360.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Intrinsic Value checker
Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.
Is PharmaCyte Biotech, Inc. (PMCB) undervalued or overvalued?
Valuation verdict for PharmaCyte Biotech, Inc. will appear when live upside data is available.
Fair value vs market price — PharmaCyte Biotech, Inc. (PMCB)
Unlock premium access to view the live fair value comparison against current market price for PMCB.
Frequently Asked Questions - PMCB
Is PMCB undervalued or overvalued right now?
PMCB is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for PMCB: open their intrinsic value pages.